scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1104160729 |
P356 | DOI | 10.1038/S41586-018-0157-4 |
P932 | PMC publication ID | 6064976 |
P698 | PubMed publication ID | 29795354 |
P50 | author | Simon Cauchemez | Q28152057 |
Justin Lessler | Q37366488 | ||
Derek Cummings | Q60057514 | ||
Ananda Nisalak | Q60059374 | ||
Isabel Rodriguez-Barraquer | Q62526039 | ||
Richard G Jarman | Q66732147 | ||
Butsaya Thaisomboonsuk | Q66732175 | ||
Leah C Katzelnick | Q89811933 | ||
P2093 | author name string | Stephen Thomas | |
Chonticha Klungthong | |||
Timothy Endy | |||
Alan L Rothman | |||
In-Kyu Yoon | |||
Louis Macareo | |||
Henrik Salje | |||
Damon Ellison | |||
Alden Weg | |||
P2860 | cites work | Original antigenic sin in dengue | Q24570059 |
The global distribution and burden of dengue | Q24628768 | ||
Benefits and risks of the Sanofi-Pasteur dengue vaccine: Modeling optimal deployment | Q26746185 | ||
Dynamic effects of antibody-dependent enhancement on the fitness of viruses | Q27472667 | ||
Ecological and immunological determinants of dengue epidemics | Q27473480 | ||
Cross-protective immunity can account for the alternating epidemic pattern of dengue virus serotypes circulating in Bangkok | Q27477511 | ||
Spatial and Temporal Clustering of Dengue Virus Transmission in Thai Villages | Q27487319 | ||
Serotype-Specific Differences in the Risk of Dengue Hemorrhagic Fever: An Analysis of Data Collected in Bangkok, Thailand from 1994 to 2006 | Q27491001 | ||
Evidence That Maternal Dengue Antibodies Are Important in the Development of Dengue Hemorrhagic Fever in Infants | Q29620637 | ||
Incubation Periods of Mosquito-Borne Viral Infections: A Systematic Review | Q33332171 | ||
Clinical, epidemiologic, and virologic features of dengue in the 1998 epidemic in Nicaragua | Q33337347 | ||
A simple model for complex dynamical transitions in epidemics | Q33887980 | ||
Epidemiology of inapparent and symptomatic acute dengue virus infection: a prospective study of primary school children in Kamphaeng Phet, Thailand | Q33959784 | ||
Methods to infer transmission risk factors in complex outbreak data. | Q33989754 | ||
Efficacy of a tetravalent dengue vaccine in children in Latin America. | Q34446032 | ||
A combined analysis of immunogenicity, antibody kinetics and vaccine efficacy from phase 2 trials of the RTS,S malaria vaccine | Q34487139 | ||
Use of expansion factors to estimate the burden of dengue in Southeast Asia: a systematic analysis | Q34600668 | ||
Variability in dengue titer estimates from plaque reduction neutralization tests poses a challenge to epidemiological studies and vaccine development | Q35195545 | ||
Niche and neutral effects of acquired immunity permit coexistence of pneumococcal serotypes | Q35927343 | ||
Measuring Spatial Dependence for Infectious Disease Epidemiology | Q36022615 | ||
Revealing the microscale spatial signature of dengue transmission and immunity in an urban population | Q36066463 | ||
The Long-Term Safety, Public Health Impact, and Cost-Effectiveness of Routine Vaccination with a Recombinant, Live-Attenuated Dengue Vaccine (Dengvaxia): A Model Comparison Study | Q36206692 | ||
Asymptomatic humans transmit dengue virus to mosquitoes | Q36331893 | ||
Dengue Virus (DENV) Neutralizing Antibody Kinetics in Children After Symptomatic Primary and Postprimary DENV Infection | Q36745257 | ||
Interactions between serotypes of dengue highlight epidemiological impact of cross-immunity | Q37062703 | ||
Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection | Q38087545 | ||
Dengue diversity across spatial and temporal scales: Local structure and the effect of host population size | Q38881036 | ||
Spatial and temporal circulation of dengue virus serotypes: a prospective study of primary school children in Kamphaeng Phet, Thailand | Q38993646 | ||
Estimation of infection and recovery rates for highly polymorphic parasites when detectability is imperfect, using hidden Markov models | Q39473573 | ||
Travelling waves and spatial hierarchies in measles epidemics | Q39587669 | ||
Revisiting Rayong: shifting seroprofiles of dengue in Thailand and their implications for transmission and control | Q40229200 | ||
Dengue in the Early Febrile Phase: Viremia and Antibody Responses | Q40647864 | ||
Humoral immunity and correlation between ELISA, hemagglutination inhibition, and neutralization tests after vaccination against tick-borne encephalitis virus in children | Q42998088 | ||
Relation of pooled logistic regression to time dependent Cox regression analysis: the Framingham Heart Study | Q46977345 | ||
Antibody-dependent enhancement of severe dengue disease in humans | Q47592202 | ||
Neutralizing Antibody Correlates Analysis of Tetravalent Dengue Vaccine Efficacy Trials in Asia and Latin America | Q89453187 | ||
P433 | issue | 7707 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 719-723 | |
P577 | publication date | 2018-05-01 | |
P1433 | published in | Nature | Q180445 |
P1476 | title | Reconstruction of antibody dynamics and infection histories to evaluate dengue risk | |
P478 | volume | 557 |
Q58606057 | A Combination of Two Human Monoclonal Antibodies Prevents Zika Virus Escape Mutations in Non-human Primates |
Q66679555 | A Modified mRNA Vaccine Targeting Immunodominant NS Epitopes Protects Against Dengue Virus Infection in HLA Class I Transgenic Mice |
Q90629672 | A combination of two human monoclonal antibodies limits fetal damage by Zika virus in macaques |
Q90560585 | A review of Dengvaxia®: development to deployment |
Q99564799 | A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity |
Q99634545 | ADE and hyperinflammation in SARS-CoV2 infection- comparison with dengue hemorrhagic fever and feline infectious peritonitis |
Q94511915 | An open source tool to infer epidemiological and immunological dynamics from serological data: Serosolver |
Q62485190 | Antigenic cross-reactivity between Zika and dengue viruses: is it time to develop a universal vaccine? |
Q83225458 | Broadly neutralizing human antibodies against dengue virus identified by single B cell transcriptomics |
Q56373585 | Challenges and opportunities in controlling mosquito-borne infections |
Q99370861 | Climate change could shift disease burden from malaria to arboviruses in Africa |
Q96165179 | Combine dengue vaccines to optimize effectiveness |
Q66679685 | Cross-Reactive T Cell Immunity to Dengue and Zika Viruses: New Insights Into Vaccine Development |
Q93116456 | Cross-serotype interactions and disease outcome prediction of dengue infections in Vietnam |
Q91271250 | Dengue |
Q99574588 | Dengue and Zika virus infections are enhanced by live attenuated dengue vaccine but not by recombinant DSV4 vaccine candidate in mouse models |
Q83229772 | Dengue genetic divergence generates within-serotype antigenic variation, but serotypes dominate evolutionary dynamics |
Q59352698 | Dengue: a growing threat requiring vaccine development for disease prevention |
Q64099613 | Detection of post-vaccination enhanced dengue virus infection in macaques: An improved model for early assessment of dengue vaccines |
Q95268372 | Dynamics of antibodies to SARS-CoV-2 in a case with SARS-CoV-2 infection |
Q64081724 | Effects of infection history on dengue virus infection and pathogenicity |
Q83229071 | Enteropathogen antibody dynamics and force of infection among children in low-resource settings |
Q63246260 | Global expansion and redistribution of Aedes-borne virus transmission risk with climate change |
Q100694566 | Learning from the past: development of safe and effective COVID-19 vaccines |
Q66679636 | Longitudinal Analysis of Memory B and T Cell Responses to Dengue Virus in a 5-Year Prospective Cohort Study in Thailand |
Q66679750 | Molecular Simulations Reveal the Role of Antibody Fine Specificity and Viral Maturation State on Antibody-Dependent Enhancement of Infection in Dengue Virus |
Q64066509 | Nationally-representative serostudy of dengue in Bangladesh allows generalizable disease burden estimates |
Q90472263 | Primary and secondary dengue virus infections elicit similar memory B cell responses but breadth to other serotypes and cross-reactivity to Zika virus is higher in secondary dengue |
Q99731978 | Protective and enhancing interactions among dengue viruses 1-4 and Zika virus |
Q92859173 | Recent advances in understanding dengue |
Q99588194 | Reemergence of dengue virus in Bangladesh: Current fatality and the required knowledge |
Q58102330 | Risk of Dengue in Travelers: Implications for Dengue Vaccination |
Q92622870 | Risk of Zika microcephaly correlates with features of maternal antibodies |
Q101226405 | Risk of dengue virus infection according to serostatus in individuals from dengue endemic areas of Mexico |
Q90205634 | Serologic Tools and Strategies to Support Intervention Trials to Combat Zika Virus Infection and Disease |
Q90109621 | Spatiotemporal variability in dengue transmission intensity in Jakarta, Indonesia |
Q91967484 | The 'lifecycle' of human beings: a call to explore vector-borne diseases from an ecosystem perspective |
Q98386109 | The role of IgG Fc receptors in antibody-dependent enhancement |
Q91732033 | Thermal biology of mosquito-borne disease |
Q91173745 | Tracking the polyclonal neutralizing antibody response to a dengue virus serotype 1 type-specific epitope across two populations in Asia and the Americas |
Q92735295 | Using cluster analysis to reconstruct dengue exposure patterns from cross-sectional serological studies in Singapore |
Q66679530 | West Nile Virus and Usutu Virus Co-Circulation in Europe: Epidemiology and Implications |
Q66680074 | West Nile virus infection in individuals with pre-existing Usutu virus immunity, northern Italy, 2018 |
Q92441397 | Zika Virus Infection in Pregnancy: Advanced Diagnostic Approaches in Dengue-Naive and Dengue-Experienced Pregnant Women and Possible Implication for Cross-Reactivity and Cross-Protection |
Search more.